Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Harding

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
JAMA Oncology|September 22, 2022
Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular CarcinomaBinbin Zheng-Lin, David M Faleck, James J Harding
Current Opinion in HIV and AIDS|October 19, 2016
Hepatocellular carcinoma in patients with HIVImane El Dika, James J Harding, Ghassan K Abou-Alfa
Cancer|November 6, 2015
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?James J Harding, Imane El Dika, Ghassan K Abou-Alfa
Current Treatment Options in Oncology|June 27, 2016
Advanced Hepatocellular Cancer: the Current State of Future ResearchLouise C Connell, James J Harding, Ghassan K Abou-Alfa
Digestive Diseases and Sciences|March 7, 2019
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?James J Harding, Danny N Khalil, Ghassan K Abou-Alfa
Chinese Clinical Oncology|November 11, 2016
Combined intrahepatic cholangiocarcinoma and hepatocellular carcinomaLouise C Connell, James J Harding, Jinru Shia, et al.
Journal of Hepatology|September 23, 2022
Rational development of combination therapies for biliary tract cancersJames J Harding, Danny N Khalil, Luca Fabris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Learning All That We Can From MyPathwayJessica J Tao, Alison M Schram, James J Harding, et al.
JCO Precision Oncology|June 11, 2025
Prenatal Cell-Free DNA Sequencing and Intrahepatic CholangiocarcinomaIan S Goldlust, Michael V Gormally, Sara Teichholtz, et al.
Oncology Research and Treatment|March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 MutationBruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
JAMA Oncology|September 22, 2022
Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular CarcinomaBinbin Zheng-Lin, David M Faleck, James J Harding
Current Opinion in HIV and AIDS|October 19, 2016
Hepatocellular carcinoma in patients with HIVImane El Dika, James J Harding, Ghassan K Abou-Alfa
Cancer|November 6, 2015
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?James J Harding, Imane El Dika, Ghassan K Abou-Alfa
Current Treatment Options in Oncology|June 27, 2016
Advanced Hepatocellular Cancer: the Current State of Future ResearchLouise C Connell, James J Harding, Ghassan K Abou-Alfa
Digestive Diseases and Sciences|March 7, 2019
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?James J Harding, Danny N Khalil, Ghassan K Abou-Alfa
Chinese Clinical Oncology|November 11, 2016
Combined intrahepatic cholangiocarcinoma and hepatocellular carcinomaLouise C Connell, James J Harding, Jinru Shia, et al.
Journal of Hepatology|September 23, 2022
Rational development of combination therapies for biliary tract cancersJames J Harding, Danny N Khalil, Luca Fabris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Learning All That We Can From MyPathwayJessica J Tao, Alison M Schram, James J Harding, et al.
JCO Precision Oncology|June 11, 2025
Prenatal Cell-Free DNA Sequencing and Intrahepatic CholangiocarcinomaIan S Goldlust, Michael V Gormally, Sara Teichholtz, et al.
Oncology Research and Treatment|March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 MutationBruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Pageof 14